Hadas Sara Hershkovich

This inventor holds 23 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 16 EPO patents, primarily in Tumor Treatment Technologies. Top assignees: Novocure Gmbh, Other. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hadas Sara Hershkovich. Retrieved from https://idiyas.com/inventor/hadas-sara-hershkovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 16 (Patent Applications = 17)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 144(Granted Patents)

Location History:

Kiryat Motzkin, IL (2019 - 2024)
Haifa, IL (2023 - 2024)

Company Filing History:

22 out of 223

Novocure Gmbh

patents

1 out of 834,570

Other

patents

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Tumor Treating Fields

Electric Impedance

Transducer Arrays

Blood Brain Barrier

Dose Quantification

Treatment Planning

Implantable Devices

AC Conductivity

Electrode Positioning

Longitudinal Delivery

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12515045 - Treatment planning for tumor treating fields (2026-01-06),

2. 12515044 - Using power loss density and related measures to quantify the dose of tumor treating fields (TTFields) (2026-01-06),

3. 12397167 - Compositions and methods of altering the electric impedance to an alternating electric field (2025-08-26),

4. 12394148 - Methods, systems, and apparatuses for managing transducer array placement (2025-08-19),

5. 12311136 - Using alternating electric fields to increase permeability of the blood brain barrier (2025-05-27),

6. 12290654 - Using alternating electric fields to increase permeability of the blood brain barrier (2025-05-06),

7. 12285605 - Delivering tumor treating fields (TTFields) using implantable transducer arrays (2025-04-29),

8. 12282309 - Methods, systems, and apparatuses for guiding transducer array placement (2025-04-21),

9. 12076556 - Compositions and methods of altering the electric impedance to an alternating electric field (2024-09-03),

10. 11964146 - Arrays for longitudinal delivery of TTFields to a body (2024-04-23),

11. 11911612 - Using power loss density and related measures to quantify the dose of tumor treating fields (TTFields) (2024-02-27),

12. 11857782 - Delivering tumor treating fields (TTFields) using implantable transducer arrays (2024-01-02),

13. 11833362 - Compositions and methods of altering the electric impedance to an alternating electric field (2023-12-05),

14. 11650277 - TTField treatment with optimization of electrode positions based on low frequency (<1MHZ) AC conductivity estimates derived from two MRI images having different repetition times (2023-05-16),

15. 11620789 - Methods, systems, and apparatuses for managing transducer array placement (2023-04-04),

Title: The Innovative Mind of Hadas Sara Hershkovich

Introduction:

Hadas Sara Hershkovich, a talented inventor based in Kiryat Motzkin, IL, has made significant contributions to the field of medical technology with a total of 15 patents under her name. Her groundbreaking work focuses on altering electric impedance and improving nanoparticle transport across cell membranes for enhanced treatment outcomes.

Latest Patents:

Hershkovich's recent patents showcase her deep understanding of utilizing alternating electric fields for medical purposes. One of her notable inventions includes compositions and methods for altering electric impedance to an alternating electric field in a target site of a subject. Additionally, she has developed innovative arrays for the longitudinal delivery of TTFields to treat tumors in specific regions of the body, such as the torso, head, and arms.

Career Highlights:

Throughout her career, Hershkovich has made remarkable strides in the field of medical technology. She has been associated with companies like Novocure GmbH, where she has played a pivotal role in developing cutting-edge solutions for cancer treatment. Her expertise in applying AC electric fields for therapeutic purposes has earned her recognition as a leading innovator in the industry.

Collaborations:

Hershkovich has collaborated with esteemed professionals in the field, including Zeev Bomzon and Tali Voloshin-Sela. Together, they have worked on projects aimed at improving treatment outcomes for patients with cancer by leveraging innovative technologies and novel approaches.

Conclusion:

In conclusion, Hadas Sara Hershkovich's innovative spirit and dedication to medical advancements have positioned her as a trailblazer in the field of medical technology. Her patents and collaborations reflect her commitment to improving the lives of patients through groundbreaking inventions and novel treatment methods. Hershkovich's contributions will continue to have a lasting impact on the healthcare industry for years to come.

Profile summary based on public USPTO records.